// App-Quantinova.ai

141 : Targeting TGFβ signaling in BRAF mutant melanoma

Researchers

Presenter

  • L. Spender

Principal Investigators

  • S. Liu

  • C. Cui

  • R. Girotti

  • O. Sansom

  • M. Frame

  • P. ten Dijke

  • R. Marais

  • G. Inman

Medical Centers

  • The University of Edinburgh, Edinburgh, United Kingdom

  • University of Dundee, Dundee, United Kingdom

  • CRUK Manchester Institute, Manchester, United Kingdom

  • Beatson Institute, Glasgow, United Kingdom

  • University of Leiden, Leiden, Netherlands

Locations

  • United Kingdom

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Melanoma

Biomarkers

  • Mitogen-activated protein kinase

  • B-Raf proto-oncogene, serine/threonine kinase

  • Transforming Growth Factor Beta Receptor 1

Drug/Treatment

  • Vemurafenib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved